https://nl.marketscreener.com/koers/aandeel/ARROWHEAD-PHARMACEUTICALS-26864651/nieuws/Arrowhead-Pharmaceuticals-start-Fase-1-2a-studie-met-ARO-DM1-voor-de-behandeling-van-type-1-myotone-46129512/?utm_source=telegram&utm_medium=social&utm_campaign=share